We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VPTDF market cap is 11.22M. The company's latest EPS is CAD -0.0302 and P/E is -3.31.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 176k | 270k | 0 | 68k | 49k |
| Operating Income | -3.23M | -1.65M | -3.72M | -4.91M | -4.93M |
| Net Income | -3.32M | -1.85M | -3.88M | -4.87M | -4.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 314k | 802k | 9.54M | 5.98M | 1.88M |
| Total Liabilities | 2.78M | 3.15M | 1.21M | 1.42M | 1.69M |
| Total Equity | -2.47M | -2.35M | 8.33M | 4.55M | 189k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.38M | -1.1M | -3.15M | -4.14M | -3.8M |
| Investing | -17k | -4k | -4k | N/A | N/A |
| Financing | 2.35M | 1.62M | 11.89M | 87k | -102k |
| Market Cap | 11.22M |
| Price to Earnings Ratio | -3.31 |
| Price to Sales Ratio | 333.33 |
| Price to Cash Ratio | 12.5 |
| Price to Book Ratio | 85.4 |
| Dividend Yield | - |
| Shares Outstanding | 161.41M |
| Average Volume (1 week) | 49.6k |
| Average Volume (1 Month) | 101.34k |
| 52 Week Change | -68.26% |
| 52 Week High | 0.2687 |
| 52 Week Low | 0.057 |
| Spread (Intraday) | 0.03 (30.12%) |
| Company Name | VentriPoint Diagnostics Ltd (QB) |
| Address |
18 hook avenue, unit 101 toronto, ontario M6P 1T4 |
| Website | https://ventripoint.com/ |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
